Skip to content

Clinical trials

Head and Neck Neoplasms trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Head and Neck Neoplasms Country / region: Netherlands Clear all

101 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20013
20031
20042
20052
20063
20071
20083
20093
20102
20114
20123
20132
20142
20156
20166
201711
20198
20205
20217
20226
20239
20242
20255
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed46
Recruiting18
Terminated15
Active, not recruiting10
Unknown status10
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Radboud University Medical Center14
The Netherlands Cancer Institute12
University Medical Center Groningen10
European Organisation for Research and Treatment of Cancer - EORTC7
Maastricht Radiation Oncology6
Hoffmann-La Roche5
Erasmus Medical Center4
Maastricht University Medical Center3
ALX Oncology Inc.2
Boehringer Ingelheim2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Head and Neck Neoplasms101
Squamous Cell Carcinoma of Head and Neck28
Carcinoma, Non-Small-Cell Lung11
Neoplasms11
Breast Neoplasms10
Lung Neoplasms10
Melanoma8
Colorectal Neoplasms7
Oropharyngeal Neoplasms7
Carcinoma, Renal Cell6

Trials

Showing 1 to 25 of 101. Each trial links to its page on Pharma Observatory.

1 more trial matches. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.